NIDA Home > Funding | |
Guidelines for the Funding of Competitive Renewal Grants |
|
April 2005Scientific opportunities in the area of drug abuse research are tremendous, and growing exponentially. This rate of growth has put significant pressure on the budget of NIDA to continue to successfully meet its broad mandated mission. The successful operation of any research grant program requires that consideration be given to a number of competing goals: how to balance the needs of an expanding existing project for increased funding, while also meeting the needs of new projects for sufficient funds; how to appropriately support the existing pool of scientists, while still allowing for opportunities to expand and to broaden the pool of scientific talent; and how to appropriately support the existing pool of research, while still allowing for opportunities to broaden the types of research questions being addressed and the methodologies being used. In this context, on the advice of the National Advisory Council on Drug Abuse, the NIDA has established cost management guidelines for the funding of the competitive renewal of prior grant awards. Definition of Grant Terms:
Cost Management Guidelines:
Implementation of these guidelines will require the joint efforts of applicants, IRG reviewers, and program staff. It is recognized that implementation may result in some changes to related practices. In this context, it is important to bear in mind that, while competing renewals (Type 2s) may involve an expansion of an existing project, they are, by definition, intended to support the continuation of the particular project(s) that had been funded under the Type 5 grant -- research which substantially changes the research that had been funded under the previous Type 5 should, by definition, be submitted as a separate new, Type 1, grant. |
|
NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version
|